Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma

Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma

PurposeMerkel cell carcinoma (MCC) is a highly malignant cancer associated with dismal survival outcomes. Surgery is the cornerstone for the management of MCC, but the benefit of radiotherapy (RT) and chemotherapy (CT) is still controversial. We aimed to investigate the prognostic value of RT and CT...

Full description

Bibliographic Details
Main Authors: Aihong Bi, Sifu Yang, Yang Ding, Yong Yu, Wenming Zhan, Tao Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Medicine
Subjects:
merkel cell carcinoma
SEER
radiotherapy
chemotherapy
survival
prognostic factor
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.845905/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.845905/full

Similar Items